#fibric | Explore Tumblr posts and blogs

lupine-publishers-rrhoaj · 3 years ago

Text

Lupine Publishers|Why to Not Rely on Nature?

Lupine Publishers | Journal of Health Research and Reviews

Abstract

Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system (enzymes) break the food parts down into sugars and acids, your body’s fuel. Your body can use this fuel right away, or it can store the energy in your body tissues. If you have a metabolic disorder, something goes wrong with this process. Dyslipidemia is main etiological factor leading to develop coronary artery disease (CAD). Allopathic drugs used in cure of hyperlipidemia, have unwanted effects, so have poor compliance. Now a day’s nutraceuticals are getting popularity due to their moderate hypolipidemic actions with fewer adverse effects. Niacin or vitamin B-3 is used as hypolipidemic agent which increases HDL-cholesterol and decreases LDL-cholesterol, VLDL, TGs by different mechanisms. But its main adverse effects are flushing due to synthesis of Prostaglandin D-2 which has vasodilatory effect causing flushing. Cardamom is herb having hypolipidemic potential if used in specific concentration for long time. In this work we did try to compare these two medicines hypolipidemic effects. Study was single blind placebo-controlled conducted at Jinnah Hospital Lahore-Pakistan from July to November 2018. Seventy-five hyperlipidemic patients were selected and divided in three groups. Their base line lipid profile was determined at laboratory of the hospital. Patients were divided in three groups. Group-1 was on placebo therapy, Group-II was on Niacin 1.5 grams daily in divided doses, and Group-III was on Cardamom 1 gram daily in three divided doses. It was two months therapeutic design. At completion of therapeutic regimen after two months we measured all patient’s lipid profile. When results were compiled and pre and post treatment values were analyzed statistically, it was observed that both drugs hypolipidemic potential is different, although both have hypolipidemic characteristic, but Niacin is the best for treating Hyperlipidemia. For statistical analysis we used SPSS version 5.0 and paired ‘t’ test was applied to understand significant changes in two tested group’s lipid profile.

Introduction

Lipid metabolism disorders, such as Gaucher disease and Tay- Sachs disease, involve lipids. Lipids are fats or fat-like substances. They include oils, fatty acids, waxes, and cholesterol. If you have one of these disorders, you may not have enough enzymes to break down lipids. Or the enzymes may not work properly, and your body can’t convert the fats into energy. They cause a harmful amount of lipids to build up in your body. Over time, that can damage your cells and tissues, especially in the brain, peripheral nervous system, liver, spleen, and bone marrow. Many of these disorders can be very serious, or sometimes even fatal. High LDL-cholesterol and low HDL-cholesterol in blood are cause of synthesis of atherosclerotic plaques which get deposited with inner endothelium of coronary arteries, leading to develop coronary artery disease (CAD) [1,2]. Hyperlipidemia either primary or secondary is challenge for scientists of 21st century due to this disease’s complications like coronary artery disease, Hypertension, Cardiac Arrhythmias, and Myocardial Infarction [3,4]. Hyperlipidemia causes LDL particle’s oxidation, which initiate formation of atherosclerotic plaques leading to development of coronary artery disease. From this single complication of Hyperlipidemia, all major heart diseases are developed leading to morbidity and mortality due to last lethal major heart disease Ventricular Fibrillation [5-8]. Hypolipidemic drugs commonly used include Statins, nicotinic acid, bile acid binding resins and fibric acids, but all have potential for low patient compliance due to wide range of side effects [9].

Niacin increases apolipoprotein A1 levels due to anti catabolic effects resulting in higher reverse cholesterol transport. It also inhibits HDL hepatic uptake, down-regulating production of the cholesterol ester transfer protein gene. Finally, it stimulates the ABC-A1 transporter in monocytes and macrophages and upregulates peroxisome proliferator-activated receptor γ results in reverse cholesterol transport. It reduces secondary outcomes associated with atherosclerosis, such as low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and triglycerides, but increases high density lipoprotein cholesterol [10]. Despite the importance of other cardiovascular risk factors, high HDL was associated with fewer cardiovascular events independent of LDL reduction. Other effects include anti-thrombotic and vascular inflammation, improving endothelial function [11]. To get good drug-patient compliance many health-related modern researchers have started to put their haeling potential for developing alternatives drugs used in primary or secondary Hyperlipidemia. Cardamom or in urdu ILAICHI is one of the hypolipidemic herb, widely encouraged by cardiologists to be used for prevention of atherogenesis, and coronary artery disease [12]. Cardamum’s antioxident effect is well established in many research studies on medicinal herbs. This nutraceutical contains Flavenoids and Phenolic compounds which scavenge Reactive Oxygen Species (ROS), reducing risk of developing CAD. Oral administration of cardamom extracts significantly reduced total cholesterol, highdensity lipoprotein (HDL), low-density lipoprotein, and very lowdensity lipoprotein and triglycerides in HL patients [13].

Patients & Method

Design: It was single blind placebo-controlled study conducted at GENERAL HOSPITAL Lahore from July to November 2018.

No of Patients: Seventy-five hyperlipidemic patients were selected and enrolled for the study. Written, already explained and approved consent was taken from all patients.

Inclusion Criteria: Inclusion criteria were age limit from 18 to 70 years of both gender male and female primary or secondary hyperlipidemic patients.

Exclusion Criteria: Patients suffering from any vital organ disease or their impaired functions were excluded from the study. Alcoholics, cigarette smokers and patients taking regular medicine for their any physical or mental disease were also excluded.

Grouping: Seventy-five patients were divided in three groups, comprising 25 patients in each group. Group-I was on placebo therapy. They were provided capsules containing grinded rice and mixed wheat. They were advised to take one capsule before meal, thrice daily for two months. Group-II patients were advised to take 1.5 grams of Niacin in three divided doses for the period of two months. Group-III were advised to take one-gram grinded green Cardamom powder mixed in black tea, thrice daily after each meal for the period of two months.

Methods Used: At start of study all patients’ blood pressure was recorded and kept in their personal file. Lipid profile of all patients was determined by Frei Dewald Method. Total-cholesterol, LDL-cholesterol and HDL-cholesterol were main parameters we required for further calculation of change in these parameters. All patients were advised to visit clinic fortnightly for their follow up. After two months therapy their lipid profile was measured again by same Frei Dewald Method. Blood Pressure of all participants was again measured and compiled for further statistical analysis.

Statistical Analysis: Data were expressed as the mean ± SEM and paired “t” test was applied to determine statistical significance as the difference. A probability value of <0.05 was considered as non-significant and P<0.001 was considered as highly significant change in the results when pre and post-treatment values were compared

Results

Results are shown in Table 1 with detail and all parameter’s values and changes in these parameters are self-explanatory.

Table 1: Results of pre and post treatment values, measured in mg/dl (tc, ldl-c, hdl-c) & mm of hg (sbp, dbp).

Current Statistics: (Pakistan SUN Secretariat Report 2017-18, P&D Department)

Discussion

Nutraceuticals like vitamins, and nutritional substances like fruits, vegetables, and indian spices are getting popularity in medical research regarding their therapeutic characteristics. Vitamin B-3 or niacin, and Cardamum (illaichi) are well known nutraceuticals which have been proved to have hypolipidemic potential. Metabolic syndrome is cluster of complications in lipid, protein and carbohydrate metabolism in human body. Hyperlipidemia is main fraction and part of this complication. High plasma LDL particles are prone to be oxidized leading to synthesis of atherosclerotic plaques which deposit to endothelial wall of arteries including coronary arteries (CAD). To reduce high plasma fats can prevent individual from being vulnerable for development of CAD. In our results two months therapy with Niacin decreased total and LDL cholesterol 13.1 and 6.7 % respectively. Statistically decrease in total cholesterol is highly significant while change in LDL-cholesterol is significant biostatistically. These results match with results of study conducted by Capuzzi DM et al. [14] who agree with our results. They almost saw same changes in LP (lipid profile) of primary and secondary hyperlipidemic patients.

They mentioned effects of blood pressure which was nonsignificant when they analyzed pre and post treatment values in systolic and diastolic blood pressure. Our results of change in HDL cholesterol also match with results of Alam K et al. [15] who proved 11% increase in HDL-cholesterol which is highly significant change in pre, and post treatment values of the parameter mentioned. Cantarella L et al. [16] proved significant change in systolic blood pressure of hyperlipidemic patients but non-significant effects on diastolic blood pressure. Goto T et al. [17] explained cause of flushing by using Niacin in hypolipidemic doses. They recommended titration of Niacin dose to improve patient drug compliance. Kawaguchi K et al. [18] did research on Cardamom and found phenolic compounds of this herb as antioxidant. They agree with many researcher’s idea or viewpoint that phenolics work as scavenger of Reactive Oxygen Species (ROS). Mittal MK et al. [19] proved that hypolipidemic effects of any herb are not as potent as Statins or Niacin. They have encouraged researchers that active ingredients of medicinal herbs should carefully be extracted and utilized efficaciously when you could preserve all for long time. Our research study proved significant changes in total and LDL cholesterol in 24 hyperlipidemic patients, i.e. 7.2 mg/dl reduction in total cholesterol and 8.8 mg/dl decrease in LDL cholesterol. Changes in both parameters are biostatistically significant.

Almost same results were observed by Bruckert, Eric et al. [20] who again said and advised patient not totally to depend on medicinal herbs, for, it is difficult to treat the disease by monotherapy when they start to develop metabolic syndrome and its serious complications. Babu PV et al. [21] has described that too much active ingredients or chemical compounds present in herbal medicines made it (Cardamom) unpopular because unexpected effects may be observed by using large amount of grinded Cardamom. He warned individuals using large amount of drug may harm metabolic pathways of body, producing unexplained metabolites which can harm body tissues. NA Lokan et al. [22], Temokarr Y et al. [23] explained that there are remarkable number of medicinal herbs and other chemical compounds which scavenge ROS (reactive oxygen species) in human body, preventing development of CAD.

For more Lupine Publishers Research and Reviews on Healthcare Open Access Journal Articles: https://lupine-publishers-research.blogspot.com/

#Lupine publishers #Lupine Publishers LLC #Lupine Publishers Group

2 notes · View notes

researchnesterinsights · 4 years ago

Text

Global Peat Market Outlook by Types, Applications, End Users and Opportunities 2022 to 2030

Research Nester published a report titled “Peat Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global peat market in terms of market segmentation by material type, application, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global peat market is estimated to occupy a large revenue by growing at a CAGR of ~14% during the forecast period, i.e., 2022 – 2030, owing to the escalating number of industrial activities around the world, growing use of renewable energy sources and high demand for food globally. Along from these, increasing population and electricity demand are also expected to drive market growth in the near future.

The global peat market is segmented by material type and application. Based on material type, the fibric segment is anticipated to grab the largest market share during the forecast period on the back of high usage of fibric peat in several applications globally. Additionally, by application, the agriculture segment is projected to acquire the largest share over the forecast period ascribing to increase in use of peat to produce organic fertilizer and as a garden soil.

Request Sample For More Information@ https://www.researchnester.com/sample-request-3334

Geographically, the market is segmented into five major regions, namely North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. Europe region is evaluated to grab the largest share in the market during the forecast period attributing to the presence of large number of peatlands in Scandinavia and British Isles, and growing usage of peat as a fuel in the region.

Growing Usage of Renewable Energy Sources to Drive Market Growth

Since the last decade, the world is highly emphasizing on generating energy that produces minimal to no greenhouse gas emissions and helps in the reduction of various types of air pollution. This is considered to be a major factor anticipated to boost the growth of the market in the upcoming years.

However, concerns associated with the pollution caused by peat burning is expected to operate as key restraint to the growth of the global peat market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global peat market which includes company profiling of Elva E.P.T. Ltd., Global Peat Ltd, Stender AG, Oulun Energia Oy, Klasmann-Deilmann GmbH, PEAT LAND UKRAINE LLC, Klasmann-Deilmann GmbH, Neova Oy, Globalcoirs, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global peat market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Grab PDF Sample For More Information@ https://www.researchnester.com/sample-request-3334

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Research Nester

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.